Clinical trial gastrointestinal cancer Immune Yunzhi by mushroomsguide December 6, 2016 A protein-bound polysaccharide immunomodulator, PSK, does not suppress the conversion from 1-(2-tetrahydrofuryl)-5-fluorouracil to 5-fluorouracil in patients with gastric cancer